Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 526783 | NSE Symbol : | ISIN : INE934C01018 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
07-Feb-2025	14-Feb-2025	Quarterly Results	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the unaudited financial results for the quarter and nine months ended December 31 2024 As per the letter enclosed. (As Per BSE Announcement Dated on 14.02.2025)
23-Oct-2024	29-Oct-2024	Quarterly Results	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve the Un-Audited Financial Results of the Company for the quarter and half-year ended 30th September 2024. DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 ,inter alia, to consider and approve Update on board meeting (As per BSE Announcement Dated on 24/10/2024) Outcome of Board Meeting is submitted (As per BSE Announcement Dated on 29/10/2024)
18-Jul-2024	25-Jul-2024	Quarterly Results	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2024 inter alia to consider and approve the Un-Audited Financial results of the Company for the quarter ended 30th June 2024. As per the letter enclosed. (As per BSE Announcement Dated on 25/07/2024)
18-Apr-2024	25-Apr-2024	Accounts	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2024 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March 2024 and recommendation of Dividend if any for the Financial Year 2023-24. The Board of Directors of the Company has recommended a Final Dividend of INR 2.50/- per Equity Share of INR 10/- each fully paid-up (25%) for the financial year 2023-24 subject to the approval of the Members at the ensuing Annual General Meeting. As per the letter enclosed. (As Per BSE Announcement Dated on 25.04.2024)
04-Jan-2024	18-Jan-2024	Quarterly Results	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/01/2024 inter alia to consider and approve Un-audited Financial Results of the Company for the quarter and nine months ended 31st December 2023 DR. AGARWAL'S EYE HOSPITAL LIMITED has informed BSE about Board Meeting to be held on 18 Jan 2024 to consider financial statements for the period ended December 2023. Financial results. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that, in terms of Regulation 30, 33 and other applicable provisions of Listing Regulations, the Board of Directors of the Company at its meeting held on January 18, 2024 commenced at 03:30 PM and concluded at 04:00 PM have inter alia approved the Un-audited financial results of the Company for the quarter and nine months ended December 31, 2023. 1) Copies of the Un-audited Financial Results and Limited Review Report issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2023 is enclosed. 2) The Company has made arrangements for the release of the Un-audited Financial results for the quarter and nine months ended December 31, 2023, in the newspaper as per the requirement of the Listing Regulations. The Un-audited Financial Results along with the Limited Review Report issued by the Statutory Auditors for the quarter and nine months ended December 31, 2023, are enclosed. Disclosure on appointment of Secretarial Auditor of the Company for the financial year 2023-24 is submitted. (As per BSE Announcement Dated on 18/01/2024)
13-Oct-2023	20-Oct-2023	Interim Dividend	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2023 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (LODR) Regulation 2015 a meeting of the Board of Directors of the Company is scheduled to be held at the Registered Office of the Company on Friday 20th October 2023 inter alia to consider: a) Un-Audited Financial Results for the quarter and half-year ended 30th September 2023. b) Declaration of Interim Dividend if any for the Financial Year 2023-24. Pursuant to Regulation 42 of SEBI (LODR) Regulations 2015 the Record Date for the purpose of Interim dividend if declared shall be 30th October 2023. If the Board considers and approves the interim dividend the rate quantum and date of payment of the Interim Dividend shall be informed to the Stock Exchange after the conclusion of the said Board Meeting. As intimated earlier in terms of the Companys Code of Internal Procedures and Conduct for Prohibition of Insider Trading the Trading Window will remain closed until 48 hours after the announcement of the aforesaid financial results. The outcome of the Board meeting held today i.e., 20th October 2023 is submitted. The Board of Directors of the Company at its meeting held today i.e., 20th October 2023, declared the interim dividend of Rs. 2.50/- (Rupees Two and Fifty Paise) per equity share of Rs. 10/- each fully paid-up, (25%) for the financial year 2023-24 to the shareholders. As informed in our earlier letter, the record date for payment of the interim dividend shall be October 31, 2023. The Dividend shall be paid/dividend warrant/demand draft shall be dispatched to the members on or before 18th November 2023. The financial results for the quarter and half year ended September 30, 2023 is submitted (As Per BSE Announcement Dated on 20/10/2023)
27-Jul-2023	04-Aug-2023	Quarterly Results	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 inter alia to consider and approve NOTICE is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 that a meeting of the Board of Directors of the Company is scheduled to be held at the Registered Office of the company on Friday 4th August 2023 inter alia to consider the Un-Audited Financial results of the Company for the quarter ended 30th June 2023. As intimated earlier in terms of the Companys Code of Internal Procedures and Conduct for Prohibition of Insider Trading the Trading Window will remain closed until 48 hours after the announcement of the aforesaid financial results. In terms of Regulation 30, 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations'), we wish to inform that the Board of Directors of the company at its meeting held today i.e., on August 04, 2023, commenced at 10.45 A.M. and concluded at 11:45 A.M. have inter alia transacted the following businesses: 1) Approved the Un-Audited Financial Results of the Company for the quarter ended June 30, 2023. Copies of the Un-Audited Financial Results and Limited Review Report issued by the Statutory Auditors of the company for the said quarter is enclosed. 2) The Company has made arrangement for release of the Un-Audited Financial Results for the quarter ended June 30, 2023, in the newspaper as per the requirement of the LODR Regulations. The unaudited financial results and the Limited Review Report issued by the Statutory Auditors for the quarter ended 30th June 2023 are submitted. The Company has also made arrangements for the release of the Unaudited financial results for the quarter ended 30th June 2023, in the newspaper as per the requirements of the LODR Regulations. (As Per BSE Announcement Dated on 04.08.2023)
28-Apr-2023	06-May-2023	Accounts	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2023 inter alia to consider and approve a) Audited Financial Results of the Company for the quarter and year ended 31st March 2023; b) Recommendation of Dividend if any for the Financial Year 2022-23; c) Declaration of Interim Dividend if any for the Financial Year 2023-24. Pursuant to Regulation 42 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we inform you that the Record Date for the purpose of Interim dividend if declared shall be 15th May 2023. If the Board of Directors considers and approves the interim dividend the rate quantum and date of payment of Interim Dividend shall be informed to Stock Exchange after the conclusion of the said Board Meeting. As intimated earlier in terms of the Companys Code of Internal Procedures and Conduct for Prohibition of Insider Trading the Trading Window will remain closed until 48 hours after the announcement of the aforesaid financial results. The Board of Directors of the Company at its meeting held today i.e. on Saturday, May 06, 2023, commenced at 06.30 p.m. and concluded at 07.45 p.m. inter alia, considered and approved the following: i) Audited Financial Results: The Audited Financial Results of the Company for the year ended 31st March 2023 and financial results for the quarter ended 31st March 2023. Copy of the same is enclosed along with the Reports of the Statutory Auditors thereon and a declaration by the Chief Financial Officer of the Company that the said Reports of Statutory Auditors are with unmodified opinion. ii) Final Dividend: Recommended a Final Dividend of Rs.3/- per equity share of Rs.10/- each fully paid-up, (30%) for the financial year 2022-23 subject to approval of the Members at the ensuing Annual General Meeting. The Dividend shall be paid to the Members within 30 days of its declaration by the Members at the ensuing Annual General Meeting of the Company. (As Per BSE Announcement Dated on 06.05.2023)
13-Jan-2023	21-Jan-2023	Quarterly Results	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2023 inter alia to consider and approve NOTICE is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 that a meeting of the Board of Directors of the Company is scheduled to be held at the Registered Office of the company on Saturday 21st January 2023 inter alia to consider and approve the Un-Audited Financial Results of the Company for the quarter and nine months ended 31st December 2022. As intimated earlier in terms of the Companys Code of Internal Procedures and Conduct for Prohibition of Insider Trading the Trading Window will remain closed until 48 hours after the announcement of the aforesaid financial results. This is for your information and records. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that, in terms of Regulation 30, 33 and other applicable provisions of Listing Regulations, the Board of Directors of the Company at its meeting held on January 21, 2023 commenced at 12:00 Noon and concluded at 12:45 PM have inter alia approved the Un-audited financial results of the Company for the quarter and nine months ended December 31, 2022. 1) Copies of the Un-audited Financial Results and Limited Review Report issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2022 is enclosed. 2) The Company has made arrangement for release of the Un-audited Financial results for the quarter and nine months ended December 31, 2022 in the newspaper as per the requirement of the Listing Regulations. (As Per BSE Announcement Dated on 21/01/2023)
21-Oct-2022	07-Nov-2022	Quarterly Results	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2022 inter alia to consider and approve NOTICE is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 that a meeting of the Board of Directors of the Company is scheduled to be held at the Registered Office of the company on Friday 28th October 2022 inter alia to consider Un-Audited Financial Results of the Company for the quarter and half-year ended 30th September 2022. As intimated earlier in terms of the Companys Code of Internal Procedures and Conduct for Prohibition of Insider Trading the Trading Window will remain closed until 48 hours after the announcement of the aforesaid financial results. This is for your information and records. DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 ,inter alia, to consider and approve This is with reference to the earlier announcement dated October 21, 2022, given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that due to unavoidable reasons, the meeting of the Board of Directors of the Company which was scheduled to be held on Friday, 28th October 2022 has been postponed and rescheduled to Monday, November 07, 2022, inter alia, to consider Un-Audited Financial Results of the Company for the quarter and half-year ended 30th September 2022. As intimated earlier, in terms of the Company''s Code of Internal Procedures and Conduct for Prohibition of Insider Trading, the Trading Window will remain closed until 48 hours after the announcement of the aforesaid financial results. We request you to kindly take the above on record and any inconvenience caused to you is regretted. (As Per BSE Announcement Dated 27.10.2022) Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that, in terms of Regulation 30, 33 and other applicable provisions of Listing Regulations, the Board of Directors of the Company at its meeting held on November 7, 2022 commenced at 11:30 AM and concluded at 12:30 PM have inter alia approved the Un-audited financial results of the Company for the quarter and half year ended September 30, 2022. 1) Copies of the Un-audited Financial Results and Limited Review Report issued by the Statutory Auditors of the Company for the quarter and half-year ended 30th September 2022 is enclosed. 2) Cash flow statement for the half year ended September 30, 2022 is enclosed. 3) The Company has made arrangement for release of the Un-audited Financial results for the quarter and half year ended September 30, 2022 in the newspaper as per the requirement of the SEBI (LODR) Regulation, 2015. (As Per BSE Announcement Dated on 07.11.2022)
25-Jul-2022	04-Aug-2022	Quarterly Results	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2022 inter alia to consider and approve NOTICE is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 that a meeting of the Board of Directors of the Company is scheduled to be held at the Registered Office of the company on Thursday 4th August 2022 inter alia to consider and approve the Un-Audited Financial Results of the Company for the quarter ended 30th June 2022. In terms of Regulation 30, 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations'), we wish to inform that the Board of Directors of the company at its meeting held today i.e., on August 04, 2022, commenced at 11.45 A.M and concluded at 1.40 P.M. have inter alia transacted the following businesses: 1) Approved the Un-Audited Financial Results of the Company for the quarter ended June 30, 2022. Copies of the Un-Audited Financial Results and Limited Review Report issued by the Statutory Auditors of the company for the said quarter is enclosed. 2) The Company has made arrangement for release of the Un-Audited Financial Results for the quarter ended June 30, 2022, in the newspaper as per the requirement of the LODR Regulations. Kindly take the above information on record. (As Per BSE Announcement Dated 04.08.2022)
23-Jun-2022	23-Jun-2022	Change in Directors	Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is submitted
28-Apr-2022	04-May-2022	Accounts	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2022 inter alia to consider and approve NOTICE is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday 4th May 2022 inter alia to consider the Audited Financial Results of the Company for the quarter and year ended 31st March 2022 and recommendation of Dividend if any for FY 2021-22. As intimated earlier in terms of the Companys Code of Internal Procedures and Conduct for Prohibition of Insider Trading the Trading Window will remain closed until 48 hours after the announcement of the aforesaid financial results. This is for your information and records. We wish to inform that the Board of Directors of the Company at its meeting held today i.e. on Wednesday, May 04, 2022, commenced at 11.30 a.m. and concluded at 01.40 p.m. inter alia, considered and approved the following: i)The Audited Financial Results of the Company for the year ended 31st March 2022 and reviewed financial results for the quarter ended 31st March 2022. Copy of the same is enclosed along with the Reports of the Statutory Auditors thereon and a declaration by the Chief Financial Officer of the Company that the said Reports of Statutory Auditors are with unmodified opinion. ii) Recommended a dividend of Rs. 3/- per equity share of Rs.10/- each fully paid-up, (30%) for the financial year 2021-22 subject to approval of the Members at the ensuing Annual General Meeting. The Dividend shall be paid/ dividend warrant shall be dispatched to the Shareholders within 30 days of its declaration by the Shareholders at the ensuing Annual General Meeting. We wish to inform that the Board of Directors of the Company at its meeting held today i.e. on Wednesday, May 04, 2022, commenced at 11.30 a.m. and concluded at 01.40 p.m. inter alia, considered and approved the following: i) Audited Financial Results: The Audited Financial Results of the Company for the year ended 31st March 2022 and reviewed financial results for the quarter ended 31st March 2022. Copy of the same is enclosed along with the Reports of the Statutory Auditors thereon and a declaration by the Chief Financial Officer of the Company that the said Reports of Statutory Auditors are with unmodified opinion. ii) Dividend: Recommended a dividend of Rs. 3/- per equity share of Rs.10/- each fully paid-up, (30%) for the financial year 2021-22 subject to approval of the Members at the ensuing Annual General Meeting. We wish to inform that the Board of Directors of the Company at its meeting held today i.e. on Wednesday, May 04, 2022, commenced at 11.30 a.m. and concluded at 01.40 p.m. inter alia, considered and approved the following: i) The Audited Financial Results of the Company for the year ended 31st March 2022 and reviewed financial results for the quarter ended 31st March 2022. Copy of the same is enclosed along with the Reports of the Statutory Auditors thereon and a declaration by the Chief Financial Officer of the Company that the said Reports of Statutory Auditors are with unmodified opinion. ii) Recommended a dividend of Rs. 3/- per equity share of Rs.10/- each fully paid-up, (30%) for the financial year 2021-22 subject to approval of the Members at the ensuing Annual General Meeting. The Dividend shall be paid/ dividend warrant shall be dispatched to the Shareholders within 30 days of its declaration by the Shareholders at the ensuing Annual General Meeting. We wish to inform that the Board of Directors of the Company at its meeting held today i.e. on Wednesday, May 04, 2022, commenced at 11.30 a.m. and concluded at 01.40 p.m. inter alia, considered and approved the following: i)The Audited Financial Results of the Company for the year ended 31st March 2022 and reviewed financial results for the quarter ended 31st March 2022. Copy of the same is enclosed along with the Reports of the Statutory Auditors thereon and a declaration by the Chief Financial Officer of the Company that the said Reports of Statutory Auditors are with unmodified opinion. ii) Recommended a dividend of Rs. 3/- per equity share of Rs.10/- each fully paid-up, (30%) for the financial year 2021-22 subject to approval of the Members at the ensuing Annual General Meeting. The Dividend shall be paid/ dividend warrant shall be dispatched to the Shareholders within 30 days of its declaration by the Shareholders at the ensuing Annual General Meeting. (As Per BSE Announcement Dated on 04.05.2022)
19-Jan-2022	29-Jan-2022	Quarterly Results	DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2022 inter alia to consider and approve Un-Audited Financial Results of the Company for the Quarter and Nine months ended 31st December 2021. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that in terms of Regulation 30, 33 and other applicable provisions of Listing Regulations, the Board of Directors of the Company at its meeting held on January 29, 2022 commenced at 12.30 P.M and concluded at 2.00 P.M have inter alia transacted the following: 1) Approved the Un-audited financial results of the Company for the quarter and nine months ended December 31, 2021. In this regard, please find enclosed the following: i. Statement showing the Un-audited Financial Results for the quarter and nine months ended ii. Limited Review Report issued by the Statutory Auditors on the above Financial Results of the Company. 2) The Company has made arrangement for release of the Un-audited Financial results for the quarter and nine months ended December 31, 2021 in the newspaper as per the requirement of the SEBI (LODR) Regulation, 2015. (As per BSE Announcement Dated on 29/01/2022)
21-Oct-2021	29-Oct-2021	Quarterly Results	Quarterly Results Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that, in terms of Regulation 30, 33 and other applicable provisions of Listing Regulations, the Board of Directors of the Company at its meeting held on October 29, 2021 commenced at 4.15 P.M and concluded at 5.20 P.M have inter alia approved the Un-audited financial results of the Company for the quarter and half year ended September 30, 2021. (As Per BSE Announcement dated on 29.10.2021)

1 2

LOGIN HERE

Dr Agarwals Eye Hospital Ltd

Board Meeting